Genotype and allele frequency of CYP2D6 in Tamilian population

被引：0
|
作者：
C. Adithan
N. Gerard
A. T. Naveen
K. Koumaravelou
C. H. Shashindran
R. Krishnamoorthy
机构：
[1] Jawaharlal Institute of Post-graduate Medical Education and Research,Pharmacogenomics Laboratory, Department of Pharmacology
[2] Hopitàl Robert Debre,INSERM U458
来源：
European Journal of Clinical Pharmacology | 2003年 / 59卷
关键词：
CYP2D6; Genotype frequencies; Tamilians;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：517 / 520
页数：3
相关论文
共 50 条
  • [31] Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR
    Hersberger, M
    Marti-Jaun, J
    Rentsch, K
    Hänseler, E
    CLINICAL CHEMISTRY, 2000, 46 (08) : 1072 - 1077
  • [32] Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population
    Cai, W. M.
    Chen, B.
    Zhang, W. X.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 95 - 98
  • [33] The effect of CYP 2D6 genotype and CYP2D6 inhibitors on tamoxifen
    Stearns, V
    Hayes, DF
    Jin, Y
    Ullmer, L
    Nguyen, A
    Storniolo, AM
    Flockhart, U
    Desta, Z
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 5S - 5S
  • [34] Population pharmacokinetic evaluation of the relevance of CYP2D6 genotype on risperidone metabolism
    Locatelli, I
    Kastelic, M.
    Koprivsek, J.
    PHARMACOGENOMICS, 2011, 12 (03) : 312 - 313
  • [35] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [36] Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population
    Buzkova, Helena
    Pechandova, Kristina
    Slanar, Ondrej
    Perlik, Frantisek
    CELL BIOCHEMISTRY AND FUNCTION, 2008, 26 (01) : 76 - 81
  • [37] Tri-Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D6*2 and Impaired Allele CYP2D6*41
    Zanger, Ulrich M.
    Momoi, Kyoko
    Hofmann, Ute
    Schwab, Matthias
    Klein, Kathrin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (05) : 1256 - 1264
  • [38] CYP2D6*4 null allele frequency in sixteen Pakistani ethnic groups
    Ullah, Anwar
    Riaz, Sana
    Siddiqi, Saima
    Mazhar, Kehkashan
    Mansoor, Atika
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (02) : 739 - 743
  • [39] Analysis of CYP2D6 genotype and response to tetrabenazine
    Mehanna, Raja
    Hunter, Christine
    Davidson, Anthony
    Jimenez-Shahed, Joohi
    Jankovic, Joseph
    MOVEMENT DISORDERS, 2013, 28 (02) : 210 - 215
  • [40] Correlation of CYP2D6 genotype with response to tetrabenazine
    Mehanna, R.
    Hunter, C.
    Davidson, A.
    Jimenez-Shahed, J.
    Ondo, W.
    Jankovic, J.
    MOVEMENT DISORDERS, 2012, 27 : S457 - S457
12345